Table 4.
Results of Multivariate Analyses for FFR, CSS, and OS
| FFR | CSS | OS | |||||
|---|---|---|---|---|---|---|---|
| Parameter | Favor Group | Hazard Ratio | P | Hazard Ratio | P | Hazard Ratio | P |
| Galectin-1 | Neg-weak staining | 0.76 | .30 | 0.69 | .42 | 0.46 | .03 |
| CD3 | Strong staining | 0.94 | .62 | 0.87 | .58 | 0.50 | .04 |
| CA IX | Neg staining | 0.71 | .21 | 0.98 | .48 | 0.88 | .70 |
| Age (years) | Young age | — | — | 0.98 | .16 | 0.97 | .02 |
| Treatment | Chemoradiotherapy | 0.54 | .06 | 0.44 | .04 | 0.64 | .32 |
| Hemoglobin (g/dL) | High | 0.80 | .03 | 0.75 | .008 | 0.88 | .30 |
| Primary site | OPX/LX | 0.32 | .001 | 0.39 | .01 | — | — |
NOTE. Boldfacing indicates parameters that achieved statistical significance on multivariate analysis.
Abbreviations: CSS, cancer-specific survival; FFR, freedom from relapse; Neg, negative; OPX/LX, oropharynx/larynx; OS, overall survival.